Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy-Reference-Cited by-同舟云学术

Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy

Published:2009-02 Issue:2 Volume:11 Page:157-166
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:

Author:

Ferrannini E.,Fonseca V.,Zinman B.,Matthews D.,Ahrén B.,Byiers S.,Shao Q.,Dejager S.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2008.00994.x/fullpdf

Reference28 articles.

1. Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes;Ahren;J Clin Endocrinol Metab,2004

2. Measurements of islet function and glucose metabolism with the dipeptidyl peptidase 4 inhibitor vildagliptin in patients with type 2 diabetes;Azuma;J Clin Endocrinol Metab,2008

3. The dipeptidyl peptidase iv inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients;Balas;J Clin Endocrinol Metab,2007

4. Vildagliptin, a dipeptidyl peptidase-iv inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes;Mari;J Clin Endocrinol Metab,2005

5. Effects of the dipeptidyl peptidase-iv inhibitor vildagliptin on incretin hormones, islet function, and postprandial glycemia in subjects with impaired glucose tolerance;Rosenstock;Diabetes Care,2008

Cited by 244 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of DPP-4 Inhibitors and Metformin Combinations in Type 2 Diabetes: A Systematic Literature Review and Network Meta-Analysis;Diabetes, Metabolic Syndrome and Obesity;2024-06

2. Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data;BMJ;2024-05-08

3. Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review and Network Meta-analysis for the American College of Physicians;Annals of Internal Medicine;2024-05

4. A Randomized, Two-Treatments, Two-Periods, Crossover, Open label, Laboratory-Blind, Single Dose Bioequivalence Study between Vildagliptin/Metformin 50 mg/1000 mg Film Coated Tablets (Sensityn^®) and Galvusmet^® 50 mg/1000 mg Film Coated Tablets in healthy adults under fed conditions;European Pharmaceutical Journal;2023-10-20

5. Sustained-Release Vildagliptin 100 mg in Type 2 Diabetes Mellitus: A Review;Cureus;2023-05-18